AQST (Aquestive Therapeutics, Inc.) Kelajakdagi narxning foydaga nisbati

Aquestive Therapeutics, Inc. (AQST) kompaniyasining rasmiy ramzlari

Aquestive Therapeutics established medications' hayot siklini uzaytiruvchi eruvchan plyonkalarni ishlab chiqishga e'tibor qaratadi. Inflyatsiyaga chidamli epilepsiya davolash vositalari biznes barqarorligini ta'minlaydi, jamoa esa mahsulotlarni tijoratlashtirishga ixtisoslashgan muhandislarning tajribasidan foydalanadi. Ushbu grafikdagi kompaniyaning oldingi P/E koeffitsiyentining o'zgarishi joriy ko'rsatkich 0.00 ekanligini ko'rsatmoqda.

aquestive.com - AQST Kapitalizatsiyaning kelajakdagi foydaga nisbati (davr: 04.07.2022 - 16.11.2026)

aquestive.com (AQST) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Fundamental baholash:Aquestive Therapeutics Inc
Aquestive Therapeutics brendining mahsuloti

Aquestive Therapeutics (AQST) daromadlari epilepsiya va allergiya bilan kasallangan bemorlar uchun innovatsion eruvchan plyonkalarning tijoratlashtirilishiga bog'liq. Kompaniyaning oldingi P/E koeffitsiyenti tendentsiyasi ushbu sotuvlarning bozor baholashiga ta'sirini aks ettiradi. Ushbu metrika joriy aksiya narxini kutilayotgan yillik sof foyda bilan doimiy solishtirish orqali hisoblanadi. Grafik tahlili baholashning muhim nuqtalarini va rentabellikning burilish nuqtalarini aniqlash imkonini beradi. Bu esa risk va o'sish o'rtasidagi muvozanatni izlab, kapitalni qulashlardan himoya qilishni ta'minlaydi.

Raqobatdosh kompaniyalar tahlili

Kelajakdagi narxning foydaga nisbati haleon.com (HLN)|KVUE (Kenvue Health) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Prognoz qilingan narx-foyda nisbati|LGND: Prognoz qilingan narxning foydaga nisbati|Amneal - Kapitalizatsiyaning kelajakdagi foydaga nisbati|PRGO: Forvard P/E multiplikatori|Alvotech Corp - Kelajakdagi narx-foyda multiplikatori|LQDA (Liquidia Corp) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati glpg.com GLPG|Kelajakdagi narxning foydaga nisbati ANI Pharmaceuticals, Inc. (ANIP)|MNKD (MannKind Corp) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori AMPH (Amphastar Pharmaceuticals Inc)|PCRX (Pacira) - Narxning kutilayotgan foydaga nisbati|SPRY - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori TBPH (Theravance Biopharma)|scPharmaceuticals (SCPH) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati SXTC (China SXT Pharmaceuticals)|Forvard P/E multiplikatori EPRX|Forvard P/E multiplikatori bioharvest.com (BHST)|Kelajakdagi narxning foydaga nisbati Invizyne Technologies EXOZ|ORMP: Narxning kelajakdagi foydaga nisbati|ENTX: Prognoz qilingan narxning foydaga nisbati|HYFT: Kelajakdagi narxning foydaga nisbati|ABVC BioPharma Inc. (ABVC) - Kelajakdagi narxning foydaga nisbati|cumberlandpharma.com (CPIX) - Forvard P/E multiplikatori|QNTM (Quantum BioPharma) - Forvard P/E multiplikatori|FGEN: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori TELO|Forvard P/E multiplikatori Rani Therapeutics Holdings (RANI)|Forvard P/E multiplikatori SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Prognoz qilingan narx-foyda nisbati|LEXX - Kelajakdagi narxning foydaga nisbati|PULM (Pulmatrix) - Narxning kelajakdagi foydaga nisbati|Pheton Holdings Ltd (PTHL) - Kelajakdagi narxning foydaga nisbati|Aptorum - Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati LYRA|Prognoz qilingan narxning foydaga nisbati Impact BioMedical Inc (IBO)|Forvard P/E multiplikatori TNFA|YCBD: Narxning kutilayotgan foydaga nisbati|Kelajakdagi narxning foydaga nisbati PainReform PRFX|altamiratherapeutics.com (CYTO) - Prognoz qilingan narx-foyda nisbati|LIPO: Prognoz qilingan narxning foydaga nisbati|OPTN (optinose.com) - Narxning kelajakdagi foydaga nisbati|PIRS: Forvard P/E multiplikatori|PROC - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|PTPI (Petros Pharma) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati QLI|Forvard P/E multiplikatori SLRN|Kapitalizatsiyaning kelajakdagi foydaga nisbati TFFP